Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Ying Lu
Based on 17 articles published since 2009
(Why 17 articles?)
||||
Expertise Level
The expertise of Ying Lu ranks in the
  • Top 2.1%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 17 articles on the topic.
Graphical view (beta)
Aliases Lu, Yin   ·   Lu, Ying
Work Locations
Details
Most likely:    Nanjing University      
2018
  • Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Center for ADR Monitoring of Jiangsu, Nanjing 210002, Jiangsu, PR China. · Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China. · School of Science, Tianjin University of Technology and Education, Tianjin 300222, PR China. · Department of Medical Oncology, Cancer Hospital, Fudan University, Shanghai 200433, PR China. · Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing 210023, PR China. · Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing 210023, PR China. Electronic address: · Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing 210023, PR China. Electronic address: · Pubmed 29550466
2015
  • Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. · Department of Pharmacy, Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, China. · Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China. · Department of Pharmacy, Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu, China. · Pubmed 26452780
  • College of Pharmacy, Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, Jiangsu, China. · Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing, 210023, China. · Jiangsu Provincial Center for Research and Development of Marine Drugs, Nanjing, 210023, Jiangsu, China. · College of Pharmacy, Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, Jiangsu, China. · Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing, 210023, China. · Jiangsu Provincial Center for Research and Development of Marine Drugs, Nanjing, 210023, Jiangsu, China. · Pubmed 26318439
2013
  • Nanjing University of Chinese Medicine, Nanjing 210046, China. · Pubmed 23664560
  • Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China. · Pubmed 23437168
2012
  • Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China. · Pubmed 22983392
2011
  • College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China. · Pubmed 20920565
  • Department of Clinical Pharmacy, School of Pharmacy, Nanjing University of Chinese Medicine, 282 Hanzhong Road, 210029 Nanjing, Jiangsu, People's Republic of China. · Pubmed 20820782
  • College of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Highway, 210046 Nanjing, China. · Pubmed 20563582
2010
  • Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China. · Pubmed 20621088
2009
  • College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210029, China. · Pubmed 19523924
  • College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China. · Pubmed 19483477
Probable:    Stanford University   Contact    
2018
  • California Pacific Medical Center, San Francisco, CA, USA. · California Pacific Medical Center, San Francisco, CA, USA. · Stanford University, Stanford, CA, USA. · Pubmed 30105436
2017
  • Center for Melanoma Research & Treatment, California Pacific Medical Center, 2340 Clay Street, 2nd Floor, San Francisco, CA, 94115, USA. · Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico. · Consorcio de Universidades Mexicanas (CuMEX), Pachuca, Mexico. · Departments of Biomedical Data Science, Health Research and Policy, and Radiology, The Stanford Cancer Institute, Stanford University, Stanford, CA, USA. · University of Nevada, Las Vegas, Las Vegas, NV, USA. · Department of Dermatology, University of California, San Francisco, CA, USA. · Center for Melanoma Research & Treatment, California Pacific Medical Center, 2340 Clay Street, 2nd Floor, San Francisco, CA, 94115, USA. · Pubmed 28699042
Probable:    Harvard University Boston   Contact    
2017
  • Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts. · Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Department of Systems Biology, Harvard Medical School, Boston, Massachusetts. · Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology and Frontier Institute of Life Science, FIST, Xi'an Jiaotong University, Xi'an 710049, P.R. China. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts. · Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Pubmed 28174173
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 17 total) written by Ying Lu about Melanoma:

  • Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery. 2018
  • A spontaneous metastatic mathematical model in mice for screening anti-metastatic agents. 2018
  • Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin? 2017
  • The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function. 2017
  • Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways. 2015
  • Holothurian glycosaminoglycan inhibits metastasis via inhibition of P-selectin in B16F10 melanoma cells. 2015
  • Characterization of xanthatin: anticancer properties and mechanisms of inhibited murine melanoma in vitro and in vivo. 2013
  • Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor-κB/tissue factor/Factor Xa pathway in melanoma B16F10 cells. 2013
  • Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition. 2012
  • Anti-angiogenesis effect of essential oil from Curcuma zedoaria in vitro and in vivo. 2011
Show List of Full Article Records
Google Searches

Learn more about Ying Lu using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Nanjing University
Stanford University
Harvard University Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Nanjing University
2018
  • Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Center for ADR Monitoring of Jiangsu, Nanjing 210002, Jiangsu, PR China. · Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China. · School of Science, Tianjin University of Technology and Education, Tianjin 300222, PR China. · Department of Medical Oncology, Cancer Hospital, Fudan University, Shanghai 200433, PR China. · Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing 210023, PR China. · Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing 210023, PR China. Electronic address: · Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing 210023, PR China. Electronic address: · Pubmed 29550466
2015
  • Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. · Department of Pharmacy, Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, China. · Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China. · Department of Pharmacy, Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu, China. · Pubmed 26452780
  • College of Pharmacy, Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, Jiangsu, China. · Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing, 210023, China. · Jiangsu Provincial Center for Research and Development of Marine Drugs, Nanjing, 210023, Jiangsu, China. · College of Pharmacy, Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, Jiangsu, China. · Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing, 210023, China. · Jiangsu Provincial Center for Research and Development of Marine Drugs, Nanjing, 210023, Jiangsu, China. · Pubmed 26318439
2013
  • Nanjing University of Chinese Medicine, Nanjing 210046, China. · Pubmed 23664560
  • Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China. · Pubmed 23437168
2012
  • Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China. · Pubmed 22983392
2011
  • College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China. · Pubmed 20920565
  • Department of Clinical Pharmacy, School of Pharmacy, Nanjing University of Chinese Medicine, 282 Hanzhong Road, 210029 Nanjing, Jiangsu, People's Republic of China. · Pubmed 20820782
  • College of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Highway, 210046 Nanjing, China. · Pubmed 20563582
2010
  • Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China. · Pubmed 20621088
2009
  • College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210029, China. · Pubmed 19523924
  • College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China. · Pubmed 19483477
Stanford University
2018
  • California Pacific Medical Center, San Francisco, CA, USA. · California Pacific Medical Center, San Francisco, CA, USA. · Stanford University, Stanford, CA, USA. · Pubmed 30105436
2017
  • Center for Melanoma Research & Treatment, California Pacific Medical Center, 2340 Clay Street, 2nd Floor, San Francisco, CA, 94115, USA. · Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico. · Consorcio de Universidades Mexicanas (CuMEX), Pachuca, Mexico. · Departments of Biomedical Data Science, Health Research and Policy, and Radiology, The Stanford Cancer Institute, Stanford University, Stanford, CA, USA. · University of Nevada, Las Vegas, Las Vegas, NV, USA. · Department of Dermatology, University of California, San Francisco, CA, USA. · Center for Melanoma Research & Treatment, California Pacific Medical Center, 2340 Clay Street, 2nd Floor, San Francisco, CA, 94115, USA. · Pubmed 28699042
Harvard University Boston
2017
  • Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts. · Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Department of Systems Biology, Harvard Medical School, Boston, Massachusetts. · Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology and Frontier Institute of Life Science, FIST, Xi'an Jiaotong University, Xi'an 710049, P.R. China. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts. · Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Pubmed 28174173
Miscellaneous institutions in Nanjing
2015
  • College of Pharmacy, Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, Jiangsu, China. · Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing, 210023, China. · Jiangsu Provincial Center for Research and Development of Marine Drugs, Nanjing, 210023, Jiangsu, China. · College of Pharmacy, Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, Jiangsu, China. · Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing, 210023, China. · Jiangsu Provincial Center for Research and Development of Marine Drugs, Nanjing, 210023, Jiangsu, China. · Pubmed 26318439
University of Michigan
2009
  • Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, 1000 Wall St, Ann Arbor, MI 48105, USA. · Pubmed 20008709
University of California San Francisco
2010
  • Department of Dermatology, University of California, San Francisco, San Francisco, California, USA. · Pubmed 20739950
Yearly article counts 02202021323
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.